Indegene Q1'27 Revenue Soars 39.7% YoY to ₹10,631M, EBITDA Grows 16.9%
Indegene Limited reported Q1'FY27 revenue of ₹10,631 million, a 39.7% YoY increase. EBITDA grew 16.9% to ₹1,795 million with a margin of 16.9%. PAT was ₹1,162 million. The active client base expanded to 105. Revenue per employee reached $77.1K.
The significant revenue growth, improved margins, and expansion in client base are material positive developments for the company's financial health and market position.
The company reported strong year-over-year revenue and EBITDA growth, an expanding client base, and improved profitability metrics, indicating positive business performance.
Indegene Limited has announced its financial results for the quarter ended June 30, 2026, reporting a significant year-over-year revenue growth of 39.7% in INR terms, reaching ₹10,631 million. In USD terms, the revenue grew by 26.5% YoY to $112.5 million. The company also saw a substantial increase in its active client base, which grew by 14 sequentially to 105 clients. Profitability improved, with EBITDA margins at 16.9% and PAT margins at 10.9% for the quarter. The company highlighted strong growth across its top 20 accounts and a widening client pyramid, with $1M+ clients nearly doubling since FY22. Revenue per employee also saw an increase to $77.1K. Management expressed optimism about future performance, expecting further improvements in operating leverage and profitability in the second half of the year as investments mature and engagements scale. The company also emphasized its strategic priorities for FY27, focusing on technology and industry excellence, ESG, and people/culture. Indegene continues to position itself as a new category of "Embedded Revenue Partner," operating at the intersection of healthcare and technology with a focus on GenAI-powered solutions.
What to do with a filing like this
Indegene Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indegene Limited. Read the original for the full detail.